Hydroxyprogesterone caproate
Hydroxyprogesterone caproate
Hydroxyprogesterone caproate (pronunciation: hye-DROX-ee-proe-JES-ter-one KAP-roe-ate) is a progestin medication used to prevent preterm birth in pregnant women with a history of the condition. It is a derivative of progesterone and is also known by its brand names Makena and Proluton.
Etymology
The term "hydroxyprogesterone" is derived from its chemical structure, which includes a hydroxy group (-OH) attached to a progesterone molecule. "Caproate" refers to the caproic acid ester that is attached to the hydroxyprogesterone molecule to form the complete drug.
Usage
Hydroxyprogesterone caproate is used as a form of hormone therapy to reduce the risk of preterm birth in women who have previously had at least one spontaneous preterm birth. It is administered via intramuscular injection.
Related Terms
- Progestin: A type of medication that is similar in effect to the natural female hormone progesterone.
- Preterm birth: A birth that occurs before 37 weeks of pregnancy.
- Progesterone: A hormone produced by the ovaries that plays a vital role in the menstrual cycle and in maintaining the early stages of pregnancy.
- Intramuscular injection: A shot of medicine given in a muscle.
See Also
External links
- Medical encyclopedia article on Hydroxyprogesterone caproate
- Wikipedia's article - Hydroxyprogesterone caproate
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski